Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • April 2017
  • Supplement
  • HBS Case Collection

Imprimis (D)

By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
  • Format:Print
  • | Language:English
  • | Pages:3
ShareBar

Abstract

This case is a supplement to Imprimis (A, B, & C). It describes Imprimis’s 2015 decision to develop a $1 per pill compounded alternative to Daraprim, the branded drug that had recently undergone an extreme price hike, raising its price to $750 per pill. Imprimis also created compounded alternatives to several other branded drugs and made investments to increase its manufacturing capabilities. The company now had to decide where to focus its efforts in the future. In developing innovative compounded formulations, should it base its decisions on market size, either by population or dollar size? Should it concentrate instead on the level of exploitation by the branded drug manufacturers—how much they had raised prices by, in what amount of time? Or should it decide instead based on the life-threatening nature of the disease, regardless of how many people were afflicted? The company had to balance these choices with the expansion of its core ophthalmology business while continuing to raise funds from investors.

Keywords

Decision Choices and Conditions; Growth and Development Strategy; Pharmaceutical Industry; United States

Citation

Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (D)." Harvard Business School Supplement 717-498, April 2017.
  • Purchase

About The Author

Ramon Casadesus-Masanell

Strategy
→More Publications

More from the Authors

    • November 2022
    • Faculty Research

    HBS Case Video Bosch eBike

    By: Ramon Casadesus-Masanell
    • November 2022
    • Faculty Research

    What are the lessons learned to make intrapreneurship successful in a large company

    By: Ramon Casadesus-Masanell
    • November 2022
    • Faculty Research

    What are the lessons learned from the e-bike business for other Bosch divisions

    By: Ramon Casadesus-Masanell
More from the Authors
  • HBS Case Video Bosch eBike By: Ramon Casadesus-Masanell
  • What are the lessons learned to make intrapreneurship successful in a large company By: Ramon Casadesus-Masanell
  • What are the lessons learned from the e-bike business for other Bosch divisions By: Ramon Casadesus-Masanell
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College